Table 2

Baseline Patient Characteristics for Network Meta-Analysis of CABG With and Without Manipulation of the Aorta

I. anOPCABGII. OPCABG-PCIII. OPCABG-HSIV. CABGp Value
I vs. III vs. IIII vs. IVII vs. IIIII vs. IVIII vs. IV
Age, yrs64.5 ± 10.764.1 ± 10.666.3 ± 10.263.6 ± 10.10.200.030.40<0.000010.006<0.00001
LVEF, %56.0 ± 13.052.6 ± 5.653.8 ± 13.452.7 ± 13.70.060.310.01NR0.930.00002
Diseased vessels2.6 ± 0.73.5 ± 0.63.2 ± 0.63.2 ± 0.40.140.390.0020.350.080.32
EuroSCORE4.0 ± 3.24.0 ± 3.3NR4.2 ± 2.40.40NR<0.00001NR<0.00001NR
Male77.472.079.776.90.020.520.030.35<0.00001NR
Past stroke7.46.514.13.20.020.050.0010.0010.13NR
Cerebrovascular disease14.715.527.812.10.75<0.000010.130.00020.37NR
Peripheral vascular disease11.213.9NR10.50.58NR0.30NR0.24NR
Diabetes29.836.840.434.60.100.060.060.440.14NR
Hypertension71.276.289.869.00.780.00030.23<0.000010.20NR
COPD8.66.0NR5.90.55NR0.53NR0.71NR
Past myocardial infarction47.746.3NR44.50.45NR0.72NR0.83NR
Atrial fibrillation2.32.0NRNR0.68NRNRNRNRNR
Dyslipidemia75.080.084.876.00.220.900.030.980.05NR
Heart failure14.317.2NR14.5<0.0001NR<0.00001NR0.12NR
Renal failure5.05.5NR4.50.35NR0.98NR0.73NR
LVEF <35%7.010.4NR18.80.88NR0.04NR<0.0001NR
Left-main disease25.119.5NR21.10.17NR0.32NR0.20NR
Triple vessel disease64.275.1NR76.70.03NR0.01NR0.61NR
Previous cardiac operation4.05.6NR7.00.02NR0.007NR0.30NR
Elective operation70.562.659.165.10.590.200.110.010.430.52

Values are mean ± SD or %.

COPD = chronic obstructive pulmonary disease; EuroSCORE = European System for Cardiac Operative Risk Evaluation; LVEF = left ventricular ejection fraction; other abbreviations as in Table 1.